Emergent BioSolutions Management
Management Kriterienprüfungen 1/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Joe Papa
Geschäftsführender
n/a
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | n/a |
| Amtszeit als Geschäftsführer | less than a year |
| Eigentum des Geschäftsführers | n/a |
| Durchschnittliche Amtszeit des Managements | 1.8yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 3.3yrs |
Jüngste Management Updates
Recent updates
Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way?
Oct 28
Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario
Oct 04Little Excitement Around Emergent BioSolutions Inc.'s (NYSE:EBS) Revenues As Shares Take 27% Pounding
Sep 16Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval
Aug 18Emergent BioSolutions Inc. (NYSE:EBS) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 02Emergent BioSolutions: A Much-Needed Mid-Stage Turnaround In Process
Jul 15Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
May 10New CEO Appointment A Clear Positive For Emergent BioSolutions
Feb 27Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
Dec 18Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
Nov 23Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
Aug 23Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
Aug 14Emergent BioSolutions: Making A Big Bet On Narcan
Jul 21An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued
Jun 22Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Apr 05Emergent Biosolutions Q4 2022 Earnings Preview
Feb 24An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued
Feb 16Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
Feb 15Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments
Dec 07Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance
Nov 09Geschäftsführer
Joe Papa (68 yo)
less than a year
Amtszeit
Mr. Joseph C. Papa, Jr. also known as Joe, is Independent Non-Executive Director of Milestone Pharmaceuticals Inc. since September 3, 2024. Mr. Papa serves as Executive Advisor at Water Street Healthcare P...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Executive VP | 6.7yrs | US$2.18m | 0.32% $ 1.6m | |
| Executive Vice President of Global Quality and Ethics & Compliance | 2.6yrs | US$1.68m | 0.30% $ 1.5m | |
| Senior Vice President of Products Business | 1.8yrs | US$1.06m | 0.045% $ 221.9k | |
| CEO, President & Director | less than a year | keine Daten | keine Daten | |
| Corporate Secretary and Interim General Counsel | less than a year | keine Daten | keine Daten | |
| Senior VP & Chief Human Resource Officer | 1.7yrs | keine Daten | keine Daten | |
| Senior VP | 1.7yrs | keine Daten | keine Daten | |
| Senior VP of Science & Development | 1.8yrs | keine Daten | keine Daten | |
| Senior Vice President of Manufacturing & Bioservices | no data | keine Daten | 0.089% $ 438.7k |
1.8yrs
Durchschnittliche Betriebszugehörigkeit
58.5yo
Durchschnittliches Alter
Erfahrenes Management: EBSDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.8 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, President & Director | less than a year | keine Daten | keine Daten | |
| Independent Director | 18.4yrs | US$400.23k | 0.099% $ 487.2k | |
| Independent Director | 19.8yrs | US$394.73k | 0.037% $ 180.9k | |
| Independent Director | 1.1yrs | US$397.50k | keine Daten | |
| Independent Director | 2.6yrs | US$396.99k | 0.011% $ 52.3k | |
| Independent Director | 4.1yrs | US$405.98k | 0.032% $ 156.0k | |
| Independent Non-Executive Chairman | 20.3yrs | US$535.98k | 0.070% $ 347.0k | |
| Independent Director | 8yrs | US$413.48k | 0.069% $ 337.9k | |
| Independent Director | 1.1yrs | US$398.75k | keine Daten | |
| Independent Director | 2.3yrs | US$382.23k | 0.0073% $ 36.0k |
3.3yrs
Durchschnittliche Betriebszugehörigkeit
65yo
Durchschnittliches Alter
Erfahrener Vorstand: EBSDie Vorstandsmitglieder gelten als erfahren (3.3 Jahre durchschnittliche Amtszeit).